Dopamine replacement therapy normalizes reactive step length to postural perturbations in Parkinson's disease.
Cara Herbers, Joseph Schroeder, Chiahao Lu and 7 others
PMID 36773480WHAT IT FOUND
Dopamine medication lengthened reactive step length in Parkinson's patients during automated treadmill perturbations, matching healthy controls.
No significant medication effect appeared during manual shoulder pulls. This suggests automated perturbations may detect balance improvements that clinical tests miss.
Key findings
01For automated surface translation perturbations, total reactive step length was significantly shorter in unmedicated PD patients compared to controls, and significantly shorter when off medication compared to on medication.
02For manual shoulder pull perturbations, medication had no significant effect on step length metrics.
03In the ON medication condition, PD patients' step lengths were not significantly different from controls, regardless of perturbation type.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study had a small sample size (14 PD patients). The examiner performing the shoulder pull was not blinded to the patient's medication status. The perturbations only required backward steps; forward-stepping responses were not assessed. The time and distance of the manual shoulder pull were not standardized to match the automated treadmill perturbation. Medication dosing was determined by treating clinicians for general symptom management, not specifically for balance, so doses varied between patients.
Declared interests
The authors declared no conflicts of interest. The study was supported by the National Institutes of Health (NIH).
The easy way to misread this
Do not conclude that dopamine medication is ineffective for balance because the manual shoulder pull showed no significant change. The study indicates that the clinical test may lack the sensitivity to detect the medication's effect on step length, which was clearly visible with automated perturbations.